Access Statistics for Pierre Yves Geoffard

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Activité liée au VIH dans 24 sites hospitaliers de France métropolitaine en 1995-1996 0 0 0 0 1 1 1 1
An analysis of behaviour, health, and GDP during the Covid-19 pandemic in Europe 0 0 2 2 0 12 22 22
Anxiety Increases The Willingness To Be Exposed To Covid-19 Risk Among Young Adults In France 0 0 0 6 0 0 2 32
Anxiety Increases the Willingness the Willingness to Be Exposed to Covid-19 Risk among Young Adults in France 0 0 0 8 0 0 0 16
Anxiety Increases the Willingness the Willingness to Be Exposed to Covid-19 Risk among Young Adults in France 0 0 0 2 0 0 2 18
Anxiety increases the willingness to be exposed to covid-19 risk among young adults in France 0 0 0 0 0 0 0 5
Anxiety increases the willingness to be exposed to covid-19 risk among young adults in France 0 0 0 0 0 0 3 9
Associations between anxiety and the willingness to be exposed to COVID-19 risk among French young adults during the first pandemic wave 0 0 0 4 0 0 2 4
Associations between anxiety and the willingness to be exposed to COVID-19 risk among French young adults during the first pandemic wave 0 0 0 3 0 1 2 4
Assurance maladie en Suisse: l'assurance supplémentaire nuit-elle à la concurrence sur l'assurance de base ? 0 0 0 28 0 0 0 234
Assurance maladie en Suisse: l'assurance supplémentaire nuit-elle à la concurrence sur l'assurance de base ? 0 0 0 0 0 0 0 9
Assurance maladie en Suisse: l'assurance supplémentaire nuit-elle à la concurrence sur l'assurance de base ? 0 0 0 1 0 0 2 44
Assurance maladie en Suisse: les assurances supplémentaires nuisent-elles à la concurrence sur l'assurance de base ? 0 0 0 0 0 0 0 13
Assurance maladie en Suisse: les assurances supplémentaires nuisent-elles à la concurrence sur l'assurance de base ? 0 0 0 0 0 0 1 16
Assurance maladie: la gestion du risque long 0 0 0 0 0 1 5 1,000
Cannabis: comment reprendre le contrôle ? 0 0 0 0 0 0 1 22
Cannabis: comment reprendre le contrôle ? 0 0 0 0 0 0 1 8
Changing time and emotions 0 0 0 0 0 0 1 3
Changing time and emotions 0 0 0 10 0 0 0 43
Changing time and emotions 0 0 0 1 0 0 0 9
Changing time and emotions 0 0 0 0 0 0 0 11
Child health and access to health care in France: Evidence on the role of family income 0 0 0 0 0 0 3 7
Child health and access to health care in France: Evidence on the role of family income 0 0 0 0 0 0 2 5
Child health and use of health care services in France: Evidence on the role of family income 0 0 0 19 0 0 4 21
Child health and use of health care services in France: Evidence on the role of family income 0 0 1 40 1 1 5 69
Comment analyser le fonctionnement des systèmes de santé ? 0 0 0 0 1 1 1 14
Comment lutter contre les inégalités de santé ? 0 0 0 0 0 0 0 18
Comment meurt une épidémie ? La fin du sida en débat 0 0 0 0 0 0 0 24
Comment meurt une épidémie ? La fin du sida en débat 0 0 0 0 0 0 2 14
Comportements sexuels risques et incitations: l'impact des nouveaux traitements sur la prevention du VIH 0 0 0 42 0 0 2 676
Concurrence en santé: marché des soins, marché de l'assurance 0 0 0 0 0 0 0 3
Concurrence en santé: marché des soins, marché de l'assurance 0 0 0 0 0 0 1 11
Cost-effectiveness analysis of early access to medical and social care for migrants living with HIV in France 0 0 0 10 0 0 0 29
Cost-effectiveness analysis of early access to medical and social care for migrants living with HIV in France 0 0 0 9 0 0 1 5
Data MArkets and OPtimal Sample Size Determination 0 0 0 0 1 1 3 2,835
Decomposition of Bivariate Inequality Indicesby Attributes 0 0 0 56 0 2 3 197
Decomposition of bivariate inequality indices by attributes 0 0 0 0 0 0 0 17
Decomposition of bivariate inequality indices by attributes 0 0 0 12 0 0 0 69
Decomposition of bivariate inequality indices by attributes 0 0 0 0 0 2 3 32
Decomposition of bivariate inequality indices by attributes 0 0 1 2 0 1 3 12
Discouting and Optimizing Capital Accumulation as a Variational Minmax Problem 0 0 0 0 0 0 1 280
Disease Eradication: Private vs. Public Vaccination 0 0 0 0 1 2 3 568
Dépenses de santé: l'hypothèse d'aléa moral 0 0 0 0 0 0 2 623
Economic and public health consequences of delayed access to medical care for migrants living with HIV in France 0 0 0 0 0 1 3 13
Economic and public health consequences of delayed access to medical care for migrants living with HIV in France 0 0 0 0 1 1 3 35
End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported 0 0 0 1 0 0 4 26
End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported 0 0 0 0 0 0 2 80
Family income and child health in the UK 0 0 0 3 0 0 2 25
Family income and child health in the UK 0 0 1 40 0 0 3 96
Family income and child health in the UK 0 0 0 0 0 0 3 14
Family income and child health in the UK 0 0 0 0 0 0 2 15
Gérer le risque de dépendance 0 0 0 0 0 0 0 2
Gérer le risque de dépendance 0 0 0 0 0 0 0 21
Incentive and Selection Effects in Health Insurance 0 0 0 0 0 0 4 28
L'économie du reste à charge 0 0 0 0 0 0 0 4
L'économie du reste à charge 0 0 0 0 0 0 1 15
L'équité dans le financement du système d'indemnisation: quelques éléments de réflexion, beaucoup d'incertitudes 0 0 0 0 0 0 0 11
La concurrence, c'est l'innovation ? 0 0 0 0 0 0 0 6
La concurrence, c'est l'innovation ? 0 0 0 0 0 1 2 22
La demande de prévention est-elle induite par l'offre ? 0 0 0 0 1 1 4 16
La demande de prévention est-elle induite par l'offre ? 0 0 0 0 0 1 1 8
La demande de prévention est-elle induite par l'offre ? 0 0 0 0 0 0 1 17
La lancinante réforme de l'assurance maladie 0 0 0 0 0 1 7 51
La réception d'une note du Conseil d'Analyse Économique relative à la légalisation du cannabis 0 0 1 1 0 0 1 1
La réception d'une note du Conseil d'Analyse Économique relative à la légalisation du cannabis 0 0 1 2 0 0 2 4
La régulation des dépenses de santé: comment faire ? 0 0 0 0 0 0 3 11
La régulation des dépenses de santé: comment faire ? 0 0 0 0 0 0 1 8
La régulation des secteurs de la santé: volume 6 0 0 0 0 0 0 0 8
La régulation des secteurs de la santé: volume 6 0 0 0 0 0 0 0 25
La régulation des secteurs de la santé: volume 6 0 0 0 0 0 0 0 2
La santé par quels moyens et à quels prix ? 0 0 0 0 0 0 0 30
La santé par quels moyens et à quels prix ? 0 0 0 0 0 0 0 3
La santé, par quels moyens et à quels prix ? 0 0 0 0 0 0 0 7
La santé, par quels moyens et à quels prix ? 0 0 0 0 0 0 1 8
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance 0 0 0 3 0 1 2 38
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance 0 0 0 1 0 0 2 12
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance 0 0 0 1 0 0 2 17
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance 0 0 0 1 0 1 2 22
L’AMO ne suffit plus à garantir un accès aux soins sans barrière financière 0 0 0 0 0 0 0 16
L’AMO ne suffit plus à garantir un accès aux soins sans barrière financière 0 0 0 0 0 0 2 12
Measuring Well Being Inequality 0 0 0 0 0 0 1 4
Measuring Well Being Inequality 0 0 0 0 0 0 0 10
Medical Spending in France: Concentration, Persistence and Evolution before Death 0 0 0 0 0 0 1 25
Medical Spending in France: Concentration, Persistence and Evolution before Death 0 0 0 0 0 0 2 8
Moral Hazard and the Demand for Physician Services: First Lessons from a French Natural Experiment 0 0 0 0 0 0 0 2,155
Parents' education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 22 0 1 9 87
Parents' education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 27 0 0 3 13
Parents' education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 20 0 0 1 69
Parents’ education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 0 0 0 2 19
Parents’ education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 0 0 1 3 14
Peut-on evaluer le cout d'une maladie? 0 0 0 0 0 0 0 273
Politique de santé et inégalités sociales 0 0 0 0 0 0 0 3
Politique de santé et inégalités sociales 0 0 0 0 0 0 0 19
Politiques de santé en Europe et inégalités sociales 0 0 0 0 0 0 0 13
Politiques de santé et inégalités sociales en Europe 0 0 0 0 0 0 0 12
Pour un système de santé plus efficace 0 0 0 0 0 0 2 22
Pour un système de santé plus efficace 0 0 0 31 0 1 3 88
Pricing and R&D with Related Margins 0 0 0 0 0 0 1 562
Quelle assurance contre le risque dépendance ? 0 0 0 0 0 0 0 8
Quelle assurance contre le risque dépendance ? 0 0 0 0 0 0 0 4
Quelles formes de concurrence en assurance santé ? 0 0 0 0 0 0 0 28
Quelles sont les perspectives ouvertes par l’exploitation des données administratives ? 0 0 0 0 0 0 0 6
Quelles sont les perspectives ouvertes par l’exploitation des données administratives ? 0 0 0 0 0 0 1 13
Rational Epidemics and their Public Control 0 0 0 0 0 1 7 631
Refonder l'assurance-maladie 0 0 0 10 0 0 2 48
Refonder l’assurance-maladie 0 0 0 0 0 0 3 23
Refonder l’assurance-maladie 0 0 0 0 0 0 1 7
Reforming Incentive Schemes Under Political Constraints: The Physician Agency 0 0 0 103 0 0 0 406
Reforming incentive schemes under political constraints: The physician agency 0 0 0 91 0 0 0 300
Reforming incentive schemes under political constraints: The physician agency 0 0 0 5 1 1 1 56
Reforming incentive schemes under political contraints: The physician agency 0 0 0 0 0 0 0 17
Réformer le système de remboursement pour les soins de ville, une analyse par microsimulation 0 0 0 0 0 0 0 14
Réformer le système de remboursement pour les soins de ville, une analyse par microsimulation 0 0 0 0 0 1 2 10
Santé: l'heure des choix 0 0 0 0 0 0 0 30
Santé: l'heure des choix 0 0 0 0 0 0 0 11
Scared by Foreigners and their Products? Survey Evidence from France 0 0 0 68 0 0 0 355
Separating Selection and Incentive Effects in Health Insurance 0 0 1 143 0 0 1 430
Separating Selection and Incentive Effects: an Econometric Study of Swiss Health Insurance Claims Data 0 0 0 314 0 0 2 1,074
Separating Selection and Incentive Effects: an Econometric Study of Swiss Health Insurance Claims Data 0 0 0 0 1 2 4 48
Separating selection and incentive effects in health insurance 0 0 1 7 0 0 1 32
Separating selection and incentive effects in health insurance 0 0 1 30 0 1 4 122
Socio-economic Inequalities in access to Covid-19 tests in France in 2020: Evidence from the EPICOV socio-epidemiological cohort 0 0 1 1 0 0 4 4
Socio-economic Inequalities in access to Covid-19 tests in France in 2020: Evidence from the EPICOV socio-epidemiological cohort 0 0 0 0 0 0 3 3
Socio-economic inequalities in access to COVID-19 tests in France in 2020: evidence from the EPICOV socio-epidemiological cohort 0 0 0 0 0 0 0 0
Sunspot Fluctuations around a Steady State: The Case of Multidimensional One-Step forward Looking Economic Models 0 0 0 0 0 0 1 378
The Transmission of Information through Prices: an Alternative Exploratory Assessment of Market Performance 0 0 0 0 0 0 1 246
The influence of supplementary health insurance on switching behaviour: evidence from Swiss data 0 0 0 0 0 0 1 5
The influence of supplementary health insurance on switching behaviour: evidence from Swiss data 0 0 0 0 0 3 4 38
The influence of supplementary health insurance on switching behaviour: evidence on Swiss data 0 0 0 12 1 1 2 153
The influence of supplementary health insurance on switching behaviour: evidence on Swiss data 0 0 0 2 0 0 2 32
The subjective value of a life with Down syndrome: Evidence from amniocentesis decision 0 0 0 0 0 0 1 15
The subjective value of a life with Down syndrome: Evidence from amniocentesis decision 0 0 0 0 1 1 2 6
The subjective value of a life with Down syndrome: Evidence from amnocentesis decision 0 0 0 0 0 0 3 8
The subjective value of a life with Down syndrome: Evidence from amnocentesis decision 0 0 0 0 0 0 0 2
The subjective value of a life with Down syndrome: Evidence from amnocentesis decision 0 0 0 2 1 1 3 11
Therapeutic non adherence: A rational behavior revealing patient preferences? 0 0 0 1 0 0 1 46
Therapeutic non adherence: A rational behavior revealing patient preferences? 0 0 0 0 0 0 2 7
Therapeutic non adherence: a rational behavior revealing patient preferences ? 0 0 0 4 0 0 3 37
Therapeutic non adherence: a rational behavior revealing patient preferences ? 0 0 0 23 0 0 2 162
Workplace smoking ban effects in an heterogeneous smoking population 0 0 0 2 0 0 0 20
Workplace smoking ban effects in an heterogeneous smoking population 0 0 0 47 0 0 1 134
Workplace smoking ban effects on unhappy smokers 0 0 0 0 0 0 0 43
Workplace smoking ban effects on unhappy smokers 0 0 0 0 0 0 0 6
À quoi peut servir la concurrence en assurance santé ? 0 0 0 10 0 0 0 53
Total Working Papers 0 0 11 1,283 12 48 237 16,259
10 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
5. Quelles sont les perspectives ouvertes par l’exploitation des données administratives ? 0 0 0 0 0 0 0 4
A quoi peut servir la concurrence en assurance santé ? 0 0 0 9 0 1 1 60
Associations between anxiety and the willingness to be exposed to COVID-19 risk among French young adults during the first pandemic wave 0 0 0 0 0 0 2 4
Assurance maladie en Suisse: les assurances supplémentaires nuisent-elles à la concurrence sur l'assurance de base ? 0 0 0 6 0 0 1 84
Comportements sexuels risqués et incitations. L'impact des nouveaux traitements sur la prévention du vih 0 0 0 7 0 0 2 132
Concurrence en santé: marché des soins, marché de l'assurance 0 0 1 3 0 0 1 12
Decomposition of bivariate inequality indices by attributes 0 0 1 45 0 2 5 142
Discounting and Optimizing: Capital Accumulation Problems as Variational Minmax Problems 0 0 2 30 0 0 3 130
Disease Eradication: Private versus Public Vaccination 2 2 7 414 3 5 19 1,042
Do Prices Transmit Rationally Expected Information? 0 0 0 93 0 0 2 379
Dépenses de santé: l'hypothèse d'aléa moral 0 0 3 23 0 1 8 145
Economic and public health consequences of delayed access to medical care for migrants living with HIV in France 0 1 1 4 0 1 2 23
Efficient and equilibrium allocations with stochastic differential utility 0 1 2 98 0 1 11 188
Family income and child health in the UK 0 0 0 42 0 0 4 169
Gérer le risque de dépendance 0 0 0 0 0 0 0 7
Le gradient et la transmission intergénérationnelle de la santé pendant l'enfance 0 0 1 7 0 1 4 53
Medical Spending in France: Concentration, Persistence and Evolution before Death 0 0 2 4 0 0 2 17
Moral hazard and the demand for physician services: First lessons from a French natural experiment 0 0 4 375 0 2 9 813
Parents’ education and child body weight in France: The trajectory of the gradient in the early years 0 0 0 5 0 1 4 68
Pricing and R&D When Consumption Affects Longevity 0 0 0 0 0 0 0 199
Quelle assurance contre le risque dépendance ? 0 0 0 0 0 0 0 3
Rational Epidemics and Their Public Control 0 0 0 1 1 4 13 682
Reforming incentive schemes under political constraints: the physician agency 0 0 0 4 0 0 1 24
Réformer le système de remboursement pour les soins de ville, une analyse par microsimulation 0 0 0 5 0 0 4 49
Sunspot Fluctuations around a Steady State: The Case of Multidimensional, One-Step Forward Looking Economic Models 0 0 0 70 0 0 1 353
The influence of supplementary health insurance on switching behaviour: evidence from Swiss data 0 1 1 37 0 1 2 286
The subjective value of a life with Down syndrome: Evidence from amniocentesis decision 0 0 0 3 0 0 0 30
Therapeutic non‐adherence: a rational behavior revealing patient preferences? 0 0 0 0 0 0 1 13
Workplace smoking ban effects on unhappy smokers 0 0 0 3 0 0 0 123
Total Journal Articles 2 5 25 1,288 4 20 102 5,234


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Incentive and Selection Effects in Health Insurance 0 0 2 14 0 0 2 41
Incentive and Selection Effects in Health Insurance 0 1 1 25 0 3 3 67
Total Chapters 0 1 3 39 0 3 5 108


Statistics updated 2025-07-04